Toxicity has been associated with interferon therapy, predominantly in immunocompromised patients. Side effects appear to be dose-related and were difficult to manage. However, interferon was well-tolerated and some of the toxicity may be related to the immunocompromised state.
|Number of pages||5|
|Journal||The Medical clinics of North America|
|State||Published - May 1 1986|
ASJC Scopus subject areas